[
  {
    "ts": "2025-12-09T02:12:51+00:00",
    "headline": "Is Incyte (INCY) Quietly Reframing Its R&D Story With Breakthrough Status And Legal Firepower?",
    "summary": "Incyte recently reported encouraging Phase 1 data for its mutant-CALR antibody INCA033989 in myeloproliferative neoplasms and received a U.S. FDA Breakthrough Therapy designation for essential thrombocythemia, while also naming experienced life sciences lawyer Richard Hoffman as Executive Vice President and General Counsel to lead its legal and compliance functions. Together, the promising early data, expedited regulatory status and leadership change highlight how Incyte is pairing pipeline...",
    "url": "https://finance.yahoo.com/news/incyte-incy-quietly-reframing-r-021251660.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ada89f10-67f3-32d7-81b9-3db2907db0f6",
      "content": {
        "id": "ada89f10-67f3-32d7-81b9-3db2907db0f6",
        "contentType": "STORY",
        "title": "Is Incyte (INCY) Quietly Reframing Its R&D Story With Breakthrough Status And Legal Firepower?",
        "description": "",
        "summary": "Incyte recently reported encouraging Phase 1 data for its mutant-CALR antibody INCA033989 in myeloproliferative neoplasms and received a U.S. FDA Breakthrough Therapy designation for essential thrombocythemia, while also naming experienced life sciences lawyer Richard Hoffman as Executive Vice President and General Counsel to lead its legal and compliance functions. Together, the promising early data, expedited regulatory status and leadership change highlight how Incyte is pairing pipeline...",
        "pubDate": "2025-12-09T02:12:51Z",
        "displayTime": "2025-12-09T02:12:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FqD7IP1YjoMtOLiC1foWBQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DnvRJ7zmyZqa8oFdfcLgCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-quietly-reframing-r-021251660.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-quietly-reframing-r-021251660.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]